Study: Fenofibrate not a useful strategy for decreasing COVID-19 severity

Focused chemists in lab coats and safety goggles making experiments.

After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists.

Elon Musk can’t tweet his way out of this

Previous article

Watching violent TV during the preschool years leads to later risks of psychological impairment

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News